Poland· PL-100088173

Prostavasin 60

A alprostadil product containing alprostadilum, registered in Poland by Amdipharm Limited. The same ATC class is registered in 10 of our 19 countries.

ATC C01EA01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedProstavasin 60ATCC01EA01REGISTER NO.PL-100088173PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Alprostadil is registered in 10 of 19 countries.

Countries holding a registration under ATC C01EA01 (alprostadil), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 6 of them publish a price we can compare per daily dose

Alprostadil · ATC C01EA01

10 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Alprostadilum
Manufacturer
Amdipharm Limited
Country
Poland (PL)
ATC code
C01EA01
ATC class
Alprostadil
Defined daily dose
0.5 mg, P
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909990431212

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

84 interactions on record for alprostadil.

Graded by severity as the source publishes them — 22 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Alprostadil · interactions on record

84 records

  • 22 moderate
  • 62 info

Most severe, free to view

  • LorcaserinA08AA11moderate
  • DapagliflozinA10BK01moderate
  • CanagliflozinA10BK02moderate
  • EmpagliflozinA10BK03moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Alprostadil in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All alprostadil products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Alprestil, Alprostadil Altan
  • Belgium · Caverject, Caverject Impuls
  • Bulgaria · Алпростадил Ромфарм, Проставазин
  • Cyprus · Caverject, Vitaros
  • Czechia · Alprostan, Karon
  • Germany · Alprostadil Altan, Caverject
  • Denmark · Caverject Dual, Muse
  • Estonia · Muse, Neupedix
  • Spain · Alprostadil Altan, Alprostadil Pfizer
  • Finland · Caverject Dual, Muse
  • France · Alprostadil Intsel Chimos, Alprostadil Oresund Pharma
  • United Kingdom (Northern Ireland) · Alprostadil Pfizer, Caverject
  • Greece · Caverject, Prostin Vr
  • Croatia · Prostin Vr
  • Hungary · Alprestil, Alprostadil Altan
  • Ireland · Caverject, Vitaros
  • Iceland · Caverject Dual, Vitaros
  • Italy · Alprostar, Caverject
  • Lithuania · Muse, Neupedix
  • Luxembourg · Caverject, Prostavasin
  • Latvia · Muse, Neupedix
  • Malta · Caverject
  • Netherlands · Alprostadil Recordati, Alprostadil Simple Pharma
  • Norway · Bondil, Caverject Dual
  • Portugal · Caverject, Muse
  • Romania · Alprostadil Remedia, Alprostadil Rompharm
  • Sweden · Bondil, Caverject Dual
  • Slovenia · Alprostin Vr, Caverject
  • Slovakia · Alprostan, Alprostapint

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/87147480-4dbd-4723-8466-22a1b4378ade
GET /v1/drugs/87147480-4dbd-4723-8466-22a1b4378ade?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Proszek do sporządzania roztworu do infuzji",
  "source": "urpl",
  "strength": "60 mcg",
  "packaging": "05909990431212 ¦ Rp ¦ 14184\n10 amp. 60 mcg proszku",
  "substance": "Alprostadilum 60 mcg",
  "common_name": "Alprostadilum",
  "pl_product_id": "100088173",
  "pozwolenie_nr": "04312",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about alprostadil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.